Bayer HealthCare


Dr. Olivier Brandicourt

Chief Executive Officer, Bayer HealthCare AG

Chairman of the Board of Management, Bayer HealthCare AG, Chairman of the Bayer HealthCare Executive Committee, Member of the Executive Council, Bayer AG
Dr. Olivier Brandicourt has been Chief Executive Officer and Chairman of the Board of Management of Bayer HealthCare AG since 2013. Brandicourt is responsible for leading the company’s diversified healthcare portfolio globally, encompassing pharmaceuticals, consumer care, animal health and medical care businesses.

Prior to joining Bayer HealthCare, Brandicourt served as a member of the Executive Leadership Team of Pfizer Inc. headquartered in New York, USA. As President and General Manager he led the Emerging Markets and Established Products business units. During his tenure in the US, Brandicourt also headed up Pfizer’s global Specialty and Primary Care business units until 2009 and 2012 respectively. Previously, his career at Pfizer saw him lead its Cardiology business in the US market, as well as several regional operations including Latin America, Eastern and Southern Europe, and the United Kingdom and Ireland.

Spanning a period of over 25 years in the pharmaceutical industry, Brandicourt started his career as a Medical Director for the Region Africa at Parke-Davis/Warner-Lambert. He held other senior roles in medical and marketing before being appointed the firm’s Head of Canada.

A physician by training, Brandicourt spent eight years with the Institute of Infectious and Tropical Diseases at the Pitié-Salpêtrière Hospital in Paris with a focus on malaria research in West and Central Africa. He also spent two years in the Republic of Congo as a doctor.

Olivier Brandicourt graduated from the University of Paris VII in France. He holds a medical degree with a major in infectious diseases and tropical medicine, and a master’s degree in biology. In addition, he holds an advanced degree in cellular and immunological pathophysiology from the Paris Descartes University.

Brandicourt is a member of the Council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and member of the Board of Directors and the International Board Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA). He is also an Honorary Fellow of the Royal College of Physicians in London and board member of the Children’s Aid Society in New York.


Thursday, April 30, 2015
Stockholders' Newsletter First Quarter 2015
Additional Press Events Investor Relations Events BayKomm Events

Download Center

  file(s) collected
View Download Center
Last updated: February 5, 2015 Copyright © Bayer AG